Friday, October 13, 2017 3:56:41 AM
1) volume approached 8mm in two days (maybe too much even for more than one chat room);
2) we have seen the potential with this low float (11mm O/S) if a solid news will be released;
3) stock at these levels is massively undervalued. Less then 30mm market cap for a potential blockbuster drug and a very promising oncological drug
4) pps could hold the 2,5$ (still up 50% since last week) price recently accepted by TyrNovo investors. About that, my question is: would have you accepted shares at 2,5 (when it was traded at 1,9) instead of cash if you didn’t know what was their plan?
I think that the proposals recently approved and this restructuring (merging between the holding and the subsidiary) is part of something big in the future. In other words, it could be related to some deal. As we know, US and EU deal are ongoing.
In the meanwhile, we have to wait Renal results that if positive could give to KIT-302 a great value added.
Good luck!
EnricoMania
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM